Synapse - Works

Results (2683)

Geriatric medication management: Evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (≥65 years) cancer patients

Meeting Abstract

Lichtman, S. M.; Boparai, M. K.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors

Meeting Abstract

Lassman, A. B.; Oligodendroglioma Study Group
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists

Meeting Abstract

Love, N.; Ziel, K. A.; Bylund, C.; Elder, M.; Ellis, L. M.; Grothey, A.; Meropol, N. J.; Paley, D.; Ravdin, P. M.; Saltz, L. B.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases

Meeting Abstract

Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A randomized, phase II study of ATN-224 in patients with biochemically relapsed, hormone-naive prostate cancer: A DOD/PCF Prostate Cancer Clinical Trials Consortium trial

Meeting Abstract

Lin, J.; Beer, T. M.; Ryan, C. J.; Mathew, P.; Wilding, G.; Morris, M.; Callahan, J. A.; Gordon, G.; Reich, S.; Carducci, M. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Elevated expression of VEGFR-2 and VEGFA in desmoplastic small round cell tumor (DSRCT) and activity of bevacizumab and irinotecan in a xenograft model of DSRCT

Meeting Abstract

Magnan, H. D.; Chou, T.; LaQuaglia, M. P.; Gerald, W.; Ladanyi, M.; Merchant, M. S.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Detection of locally advanced breast cancer in the I-SPY TRIAL (CALGB 150007/150012, ACRIN 6657) in the interval between routine screening

Meeting Abstract

Lin, C.; Moore, D.; DeMichele, A.; Ollila, D.; Montgomery, L.; Liu, M.; Krontiras, H.; Gomez, R.; Esserman, L.; I-SPY TRIAL Investigators
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma

Meeting Abstract

Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Interaction between sorafenib and erlotinib

Meeting Abstract

Kuhn, J. G.; Gilbert, M.; Wen, P.; Cloughesy, T.; Cooper, J.; Puduvalli, V.; DeAngelis, L.; Lieberman, F.; Lamborn, K.; Prados, M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save